TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients

Overview of attention for article published in Breast Cancer Research and Treatment, December 2011

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 4,078 followers.

TIMP-1 in combination with HER2 & TOP2A, prediction of benefit from adjuvant anthracyclines in high-risk breast cancer http://t.co/3Ds6tNDB

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.